Cite
APA Citation
Papp, K., Griffiths, C., Gordon, K., Lebwohl, M., Szapary, P. O., Wasfi, Y., Chan, D., Shen, Y. K., Ho, V., Ghislain, P. D., Strober, B., & Reich, K. (2013). sAT0287 Long-Term Safety Of Ustekinumab: 5 Years of Follow-Up from the Psoriasis Clinical Development Program Including Patients with Psoriatic Arthritis. Annals of the rheumatic diseases, 72, A680. http://access.bl.uk/ark:/81055/vdc_100135556763.0x000061